Search Results
376 items found for "HES"
- GPCR Therapeutics welcomes Dr. Ed Brennan as their new Vice President, Head of Clinical Development
He has led teams that have filed more than 10 Investigational New Drug Applications (IND), as well as In 2007 he formed IndiPharm which was a full-service Contract Research Organization whose operational headquarters were in Mumbai, India. He received his undergraduate Bachelor of Science Degree in Pharmacy from The Philadelphia College of He went on to study medicine at the Royal College of Surgeons in Ireland before receiving his Medical
- 🎧Episode 85 of the Dr. GPCR podcast is here!
GPCR podcast is here! 🎧Hear Dr. Nicholas Holliday and how he has combined his university role with his leadership of Excellerate Bioscience
- Drug Discovery Picks Up the Pace, Stays on Target
After all, he also complained that the perfect is the enemy of the good. If only Voltaire were here today to see how drug discovery is being accelerated by new technologies. He might reverse himself and declare that the perfect can in fact be the friend of the good.
- Mark Schmeizl - Dr. GPCR Podcast
He is a pro at Matchmaking the top talent in the life sciences with the industry’s leading companies.
- Jan Steyaert Named 2022 Jacob and Louise Gabbay Award Winner
Jan Steyaert will be presented with the Gabbay Award at Brandeis University on October 27 when he will
- Inversago Pharma appoints Glenn S. Vraniak as Chief Financial Officer
Vraniak served as an executive in various innovative healthcare and technology companies including GE Capital, where he served as Executive Vice President."
- Hear the sounds: the role of G protein-coupled receptors in the cochlea
in the cochlea into electrical signals, which are transmitted by spiral ganglion neurons (SGNs) and heard disorders, and the treatment for hearing loss. And A1, A2A, and CB2 activation by agonists has protective functions on noise- or drug-induced hearing Here, we review the key findings of GPCR in the cochlea and discuss the role of GPCR in the cochlea, such as stem cell fate, PCP, hearing loss, and hearing protection."
- Differences across sexes on head-twitch behavior and 5-HT2A receptor signaling in C57BL/6J mice
Here we tested the effects of DOI on head-twitch behavior (HTR) - a mouse behavioral proxy of human psychedelic
- Comparative study of neuropeptide signaling systems in Hemiptera
Neuropeptides and their receptors have been documented in many hemipteran insects, but the differences Commercial grapevines worldwide are plagued by the bug Daktulosphaira vitifoliae (Hemiptera: Sternorrhyncha Here, 33 neuropeptide precursors and 48 putative neuropeptide G protein-coupled receptor (GPCR) genes Peptides (GnRHs) system of Sternorrhyncha was differentiated from those of the other 2 suborders in Hemiptera discovered that the neuropeptide signaling systems of Sternorrhyncha were very different from those of Heteroptera
- Viral G Protein-Coupled Receptors Encoded by β- and γ-Herpesviruses
October 2022 "Herpesviruses are ancient large DNA viruses that have exploited gene capture as part of This review focuses on the vGPCRs encoded by the human β- and γ-herpesviruses. receptors from human cytomegalovirus, which encodes four vGPCRs: US27, US28, UL33, and UL78; human herpesvirus with two receptors: U12 and U51; Epstein-Barr virus with one: BILF1; and Kaposi's sarcoma-associated herpesvirus Finally, we briefly discuss the therapeutic targeting of vGPCRs as future treatment of acute and chronic herpesvirus
- Helix 8 in chemotactic receptors of the complement system
Here, we discuss recent crystal structures of inactive C5aR1 in terms of an inverted orientation of helix
- Cell Surface Calcium-Sensing Receptor Heterodimers: Mutant Gene Dosage Affects Ca 2+ Sensing but...
September 2022 Cell Surface Calcium-Sensing Receptor Heterodimers: Mutant Gene Dosage Affects Ca 2+ Sensing However, the nature of interactions between VFT units and HH bundles, and the impacts of heterozygous Herein we generated CaSR-GABAB1 and CaSR-GABAB2 chimeras subject to GABAB -dependent endoplasmic reticulum sorting to traffic mutant heterodimers to the cell surface. Mutant heterodimers containing one wild-type (WT) and one mutant VFT domain, however, corresponding to
- Serotonin Receptor 5-HT2A Regulates TrkB Receptor Function in Heteroreceptor Complexes
Here, we demonstrate a physical interaction between 5-HT2A and TrkB in vitro and in vivo using co-immunoprecipitation Heterodimerization decreased TrkB autophosphorylation, preventing its activation with agonist 7,8-DHF and hippocampus, which is in accordance with our findings demonstrating the prevalence of 5-HT2A–TrkB heteroreceptor Our data reveal the functional role of 5-HT2A–TrkB receptor heterodimerization and suggest that the regulated
- Sosei Heptares Announces Antitrust Clearance of License Agreement with Neurocrine Biosciences
December 2021 " Tokyo, Japan and Cambridge, UK, 24 December 2021 – Sosei Group Corporation (“ Sosei Heptares the HSR Act, under the terms of the License Agreement Neurocrine Biosciences has agreed to pay Sosei Heptares
- Verily links up with Sosei Heptares for GPCR drug discovery
years as researchers have discovered the vast potential for GPCR-targeting drugs in treating a range of health Among those hitching their wagons to that star are Verily and Sosei Heptares , which have struck a research The financial details of the strategic collaboration weren’t released, but Sosei Heptares ’ past two
- Artificial intelligence – faster, smarter, cheaper GPCR drug discovery
BRS-3D was used to predict subtype-selective ligands for dopamine receptors and adenosine receptors (He , Ben, Kuang, Wang & Kong, 2016; Kuang, Feng, Hu, Wang, He & Kong, 2016). 5. By integrating this data with GPCR-related knowledge, AI can help identify patient-specific GPCR targets
- Anatomy of a partnership: Cancer Research UK teams up with Sosei Heptares
August 2022 "August 10, 2022 Cancer Research UK is working with global biopharma Sosei Heptares on
- Cancer Research UK and Sosei Heptares sign agreement to advance cancer immunotherapy candidate ...
July 2022 Cancer Research UK and Sosei Heptares sign agreement to advance cancer immunotherapy candidate largest private funder of cancer research, today announce the signing of an agreement to bring Sosei Heptares
- Sosei Heptares and Kallyope Enter Collaboration to Identify and Validate Novel Gastrointestinal GPCR
May 2022 Sosei Heptares and Kallyope Enter Collaboration to Identify and Validate Novel Gastrointestinal GPCR Targets for Drug Discovery " Collaboration is part of Sosei Heptares ’ Target Identification and in drug discovery involving the gut-brain axis, will gain unique and valuable access to the Sosei Heptares
- From DNA day to GPCR genomics
April is the month of DNA Day, a special day commemorating the discovery of the DNA double helix structure The discovery of DNA's double helical structure was a scientific milestone that revolutionized molecular For example, we know that transmembrane helices move during receptor activation and that the DRY motif M., Pérez-Hernández, G., Batebi, H., Gao, Y., Eskici, G., Seven, A. ., He, F., Maul, L., Gmeiner, P., Kobilka, B. K., Hildebrand, P. W., & Skiniotis, G. (2023).
- Sosei Heptares Confirms Senior Leadership Changes to Drive the Company Through the Next Stage ...
April 2022 Sosei Heptares Confirms Senior Leadership Changes to Drive the Company Through the Next Stage Matt Barnes appointed President of Heptares Therapeutics Ltd., and Head of UK R&D Tokyo, Japan and
- HBx induces hepatocellular carcinogenesis through ARRB1-mediated autophagy to drive the G 1/S cycle
The hepatitis B virus X protein (HBx) is involved in the process of hepatocellular carcinoma via the Our previous study indicated that ARBB1 (arrestin beta 1) promotes hepatocellular carcinogenesis (HCC Herein, we identified that ARRB1 was upregulated by HBx in vivo and in vitro. Arrb1 deficiency suppressed HBx-induced hepatocellular carcinogenesis in several mouse models. carcinoma; HBV: hepatitis B virus; HBx: hepatitis B virus X protein; HMGB1: high mobility group box
- Sosei Heptares recently hosted their annual Scientific Advisory Board (SAB)
"We recently hosted our annual Scientific Advisory Board (SAB) summit at our site within Granta Park. It was great to bring everyone together and also welcome new member John Parkinson ." Read more at the source #DrGPCR #GPCR #IndustryNews
- Sosei Heptares Enters Antibody Discovery Agreement with Twist Bioscience to Discover and Develop ...
December 2022 Sosei Heptares Enters Antibody Discovery Agreement with Twist Bioscience to Discover Twist’s proprietary synthetic antibody libraries and sophisticated bioinformatics expertise with Sosei Heptares collaboration to discover therapeutic antibodies against G protein-coupled receptors (GPCR) identified by Sosei Heptares
- California gold rush for Sosei Heptares
November 2021 "Cambridge’s Japanese-owned life sciences company Sosei Heptares has clinched a lucrative
- Sosei Heptares reported its FY2021 financial result and provided an update on operational activities
February 2022 Read more at the source #DrGPCR #GPCR #IndustryNews
- Unlock the Future of GPCR Science: Breakthroughs and Courses Await | Sep 2 - Sep 8, 2024
Hello GPCR Enthusiasts, Dive into this week's exciting updates on cutting-edge GPCR research, new learning Terry Kenakin as he shares insights into what you can anticipate for the upcoming courses. Contact us at Hello@DrGPCR.com for sponsorship opportunities. receptors in acute kidney injury Ligand-Dependent and G Protein-Dependent Properties for the Sweet Taste Heterodimer
- All Aboard the GPCR Express: Your Weekly Update is here! Oct 14-20, 2024
Hello GPCR Passenger, Welcome aboard the GPCR train as it sets off on its journey. This Week’s Highlights: Congrats to: Monserrat Avila-Zozaya , our incredible contributor, for her fantastic article on Profiling Immune Cell and Platelet Transcriptomes , and we want to wish her the best of luck on her talk today at the 11th Adhesion GPCR Workshop about ' Breaking Barriers: My Journey from Mexico to the Heart of the Dr.